Cargando…

Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty

Two‐stage revision arthroplasty is the treatment of choice for periprosthetic infection, a serious complication after knee or hip arthroplasty. Our prospective clinical trial aimed to investigate the concentrations of gentamicin and vancomycin in wound exudate and tissue in two‐stage revision arthro...

Descripción completa

Detalles Bibliográficos
Autores principales: Klinder, Annett, Zaatreh, Sarah, Ellenrieder, Martin, Redanz, Sylvio, Podbielski, Andreas, Reichel, Tobias, Bösebeck, Hans, Mittelmeier, Wolfram, Bader, Rainer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586059/
https://www.ncbi.nlm.nih.gov/pubmed/30312529
http://dx.doi.org/10.1002/jbm.b.34251
_version_ 1783428830547935232
author Klinder, Annett
Zaatreh, Sarah
Ellenrieder, Martin
Redanz, Sylvio
Podbielski, Andreas
Reichel, Tobias
Bösebeck, Hans
Mittelmeier, Wolfram
Bader, Rainer
author_facet Klinder, Annett
Zaatreh, Sarah
Ellenrieder, Martin
Redanz, Sylvio
Podbielski, Andreas
Reichel, Tobias
Bösebeck, Hans
Mittelmeier, Wolfram
Bader, Rainer
author_sort Klinder, Annett
collection PubMed
description Two‐stage revision arthroplasty is the treatment of choice for periprosthetic infection, a serious complication after knee or hip arthroplasty. Our prospective clinical trial aimed to investigate the concentrations of gentamicin and vancomycin in wound exudate and tissue in two‐stage revision arthroplasty. Wound exudate and periprosthetic membrane samples were collected from 18 patients (10 hip and eight knee patients), who were due for two‐stage treatment after a periprosthetic joint infection. Samples were taken during insertion of antibiotic‐impregnated spacers and after their removal. The concentrations of gentamicin and vancomycin in wound exudates and adjacent tissue were analyzed using high‐performance liquid chromatography mass spectrometry. Average time period of spacer implantation was 13.6 weeks (9.3–22.6 weeks). The concentration of vancomycin in wound exudate decreased from a median of 43.28 μg/mL (0.28–261.22) after implantation to 0.46 μg/mL (0.13–37.47) after the removal of the spacer. In the adjacent tissue, vancomycin concentration was mainly undetectable prior to spacer implantation (0.003 μg/g [0.003–0.261]) and increased to 0.318 μg/g [0.024–484.16] at the time of spacer removal. This was also observed for gentamicin in the tissue of patients who previously had cement‐free implants (0.008 μg/g [0.008–0.087] vs. 0.164 μg/g [0.048–71.75]) while in the tissue of patients with previously cemented prosthesis, baseline concentration was already high (8.451 μg/g [0.152–42.926]). Despite the rapid decrease in antibiotics release from spacer cement observed in vitro, in vivo antibiotics are much longer detectable, especially in the adjacent soft tissue. © 2018 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials Published By Wiley Periodicals, Inc. J Biomed Mater Res B Part B, 2019. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1587–1597, 2019.
format Online
Article
Text
id pubmed-6586059
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-65860592019-07-02 Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty Klinder, Annett Zaatreh, Sarah Ellenrieder, Martin Redanz, Sylvio Podbielski, Andreas Reichel, Tobias Bösebeck, Hans Mittelmeier, Wolfram Bader, Rainer J Biomed Mater Res B Appl Biomater Clinical Device‐Related Article Two‐stage revision arthroplasty is the treatment of choice for periprosthetic infection, a serious complication after knee or hip arthroplasty. Our prospective clinical trial aimed to investigate the concentrations of gentamicin and vancomycin in wound exudate and tissue in two‐stage revision arthroplasty. Wound exudate and periprosthetic membrane samples were collected from 18 patients (10 hip and eight knee patients), who were due for two‐stage treatment after a periprosthetic joint infection. Samples were taken during insertion of antibiotic‐impregnated spacers and after their removal. The concentrations of gentamicin and vancomycin in wound exudates and adjacent tissue were analyzed using high‐performance liquid chromatography mass spectrometry. Average time period of spacer implantation was 13.6 weeks (9.3–22.6 weeks). The concentration of vancomycin in wound exudate decreased from a median of 43.28 μg/mL (0.28–261.22) after implantation to 0.46 μg/mL (0.13–37.47) after the removal of the spacer. In the adjacent tissue, vancomycin concentration was mainly undetectable prior to spacer implantation (0.003 μg/g [0.003–0.261]) and increased to 0.318 μg/g [0.024–484.16] at the time of spacer removal. This was also observed for gentamicin in the tissue of patients who previously had cement‐free implants (0.008 μg/g [0.008–0.087] vs. 0.164 μg/g [0.048–71.75]) while in the tissue of patients with previously cemented prosthesis, baseline concentration was already high (8.451 μg/g [0.152–42.926]). Despite the rapid decrease in antibiotics release from spacer cement observed in vitro, in vivo antibiotics are much longer detectable, especially in the adjacent soft tissue. © 2018 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials Published By Wiley Periodicals, Inc. J Biomed Mater Res B Part B, 2019. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1587–1597, 2019. John Wiley & Sons, Inc. 2018-10-12 2019-07 /pmc/articles/PMC6586059/ /pubmed/30312529 http://dx.doi.org/10.1002/jbm.b.34251 Text en © 2018 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Clinical Device‐Related Article
Klinder, Annett
Zaatreh, Sarah
Ellenrieder, Martin
Redanz, Sylvio
Podbielski, Andreas
Reichel, Tobias
Bösebeck, Hans
Mittelmeier, Wolfram
Bader, Rainer
Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
title Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
title_full Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
title_fullStr Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
title_full_unstemmed Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
title_short Antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
title_sort antibiotics release from cement spacers used for two‐stage treatment of implant‐associated infections after total joint arthroplasty
topic Clinical Device‐Related Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586059/
https://www.ncbi.nlm.nih.gov/pubmed/30312529
http://dx.doi.org/10.1002/jbm.b.34251
work_keys_str_mv AT klinderannett antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT zaatrehsarah antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT ellenriedermartin antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT redanzsylvio antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT podbielskiandreas antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT reicheltobias antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT bosebeckhans antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT mittelmeierwolfram antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty
AT baderrainer antibioticsreleasefromcementspacersusedfortwostagetreatmentofimplantassociatedinfectionsaftertotaljointarthroplasty